West Chester, OH, United States of America

Ashraf Traboulsi

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Procter Gamble Company. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashraf Traboulsi. Retrieved from https://idiyas.com/inventor/ashraf-traboulsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ashraf Traboulsi

Introduction

Ashraf Traboulsi is a notable inventor based in West Chester, OH (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing innovative oral dosage forms that enhance the delivery of active ingredients.

Latest Patents

Among his latest patents, Traboulsi has developed a rheological solid oral composition. This composition includes a crystallizing agent, an aqueous phase, and an oral active agent. Another notable patent is for a quick dissolving diphenhydramine oral dosage form. This formulation is designed to deliver diphenhydramine through the sublingual or buccal mucosa. It contains diphenhydramine or a pharmaceutically acceptable salt, a permeability enhancer, and a buffering agent. The buffering agent is capable of achieving a pH of about 7.0 to about 8.0, and the diphenhydramine can completely dissolve within approximately 2 minutes.

Career Highlights

Traboulsi is currently employed at The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug delivery systems, making medications more effective and user-friendly.

Collaborations

Traboulsi has collaborated with several talented individuals in his field, including Richard John Dansereau and Brian Laster. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions.

Conclusion

Ashraf Traboulsi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in creating effective oral dosage forms. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…